Huang YH - Search Results

1

Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma.

Lim M, Muquith M, Miramontes B, Lee CJ, Espinoza M, Huang YH, Hsiehchen D. Lim M, et al. Among authors: huang yh. Hepatology. 2023 Dec 1;78(6):1755-1762. doi: 10.1097/HEP.0000000000000494. Epub 2023 Jun 1. Hepatology. 2023. PMID: 37254559

2

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.

Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Lee PC, Chau GY, Lui WY, Lee SD, Wu JC. Huang YH, et al. Among authors: huang gt. J Gastroenterol Hepatol. 2005 May;20(5):765-71. doi: 10.1111/j.1440-1746.2005.03746.x. J Gastroenterol Hepatol. 2005. PMID: 15853992

3

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.

Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, Huo TI, Sheen IJ, Lee SD, Lui WY. Wu JC, et al. Among authors: huang yh. J Hepatol. 2009 Nov;51(5):890-7. doi: 10.1016/j.jhep.2009.07.009. Epub 2009 Jul 23. J Hepatol. 2009. PMID: 19747749

4

A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.

Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang JH, Lee PC, Huo TI, Lee SD. Hsu CY, et al. Among authors: huang yh. J Hepatol. 2010 Jul;53(1):108-17. doi: 10.1016/j.jhep.2010.01.038. Epub 2010 Mar 31. J Hepatol. 2010. PMID: 20451283

5

Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma.

Tsai YJ, Hsu CY, Huang YH, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee SD. Tsai YJ, et al. Among authors: huang yh. Hepatol Int. 2011 Dec;5(4):975-84. doi: 10.1007/s12072-011-9276-9. Epub 2011 Apr 30. Hepatol Int. 2011. PMID: 21533669

6

Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Lee YH, Hsu CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI, Lee SD. Lee YH, et al. Among authors: huang yh. J Gastroenterol Hepatol. 2012 Oct;27(10):1581-8. doi: 10.1111/j.1440-1746.2012.07151.x. J Gastroenterol Hepatol. 2012. PMID: 22497632

7

Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.

Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI. Hsu CY, et al. Among authors: huang yh. Hepatology. 2013 Jan;57(1):112-9. doi: 10.1002/hep.25950. Hepatology. 2013. PMID: 22806819

8

Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?

Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI. Lee YH, et al. Among authors: huang yh. J Gastroenterol Hepatol. 2013 Feb;28(2):348-56. doi: 10.1111/jgh.12062. J Gastroenterol Hepatol. 2013. PMID: 23190248

9

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC. Chen PH, et al. Among authors: huang yh. Ann Hepatol. 2013 Mar-Apr;12(2):263-73. Ann Hepatol. 2013. PMID: 23396738 Free article.

10

Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.

Hsu CY, Lee YH, Huang YH, Hsia CY, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI, Lee SD. Hsu CY, et al. Among authors: huang yh. Hepatol Int. 2013 Mar;7(1):188-98. doi: 10.1007/s12072-011-9338-z. Epub 2012 Jan 8. Hepatol Int. 2013. PMID: 26201633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,567 results

Search Page

Filters